BioCentury
ARTICLE | Company News

Harvard University endocrine, metabolic, cardiovascular news

December 3, 2007 8:00 AM UTC

The university spun out Syndexa Pharmaceuticals Corp. to develop compounds that target molecular mechanisms linking chronic inflammation to metabolic and other diseases, including Type II diabetes an...